A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

NCT00491530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

DRUG: ABT-335
DRUG: rosuvastatin calcium
DRUG: simvastatin
DRUG: atorvastatin calcium

Sponsor

Abbott